A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

NCT05655520 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
153
Enrollment
INDUSTRY
Sponsor class

Stopped Internal company decision

Conditions

Interventions

Sponsor

Supernus Pharmaceuticals, Inc.